EU provide positive approval for generic lopinavir/ritonavir

1 February 2016. Related: Antiretrovirals.

EMA newsletter

In November 2015, the European Medicines Agency (EMA) announced that the Committee for Medicinal Products for Human Use (CHMP) had given a positive opinion for a generic coformulation of lopinavir/ritonavir.

The formulation is manufactured by Mylan.

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004025/smops/Positive/human_smop_000904.jsp&mid=WC0b01ac058001d127

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004025/smops/Positive/human_smop_000904.jsp